Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Subbian, Selvakumar ^a   O'Brien, Paul ^a   Kushner, Nicole L ^a   Yang, Guibin ^a   Tsenova, Liana ^a,b   Peixoto, Blas ^a   Bandyopadhyay, Nirmalya ^c   Bader, Joel S ^c   Karakousis, Petros C ^d   Fallows, Dorothy ^a   Kaplan, Gilla ^a  

^a PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^b NYC College of Technology   (United States)

^c Johns Hopkins University   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autophagy; Genome wide transcriptome; Host pathogen interactions; Innate immunity; Latent TB infection; Mycobacterium tuberculosis; Natural killer and dendritic cell activation; Pathway analysis; Rabbit gene expression; Th1 response

Indexed keywords

TRANSCRIPTOME;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; AUTOPHAGY; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL ACTIVATION; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE MODEL; DOWN REGULATION; FEMALE; GENE EXPRESSION; IMMUNOSTIMULATION; INFECTION CONTROL; INNATE IMMUNITY; LATENT PERIOD; LUNG CLEARANCE; LUNG TUBERCULOSIS; MACROPHAGE; MICROARRAY ANALYSIS; MOLECULAR INTERACTION; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RABBIT; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; UPREGULATION;

EID: 84874833327     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-16     Document Type: Article

References (60)

1. WHO, Global tuberculosis control: WHO report 2011 Geneva, Switzerland: World Health Organization 2011
2. Redefining latent tuberculosis. Sridhar S, Pollock K, Lalvani A, Future Microbiol 2011 6 9 1021 1035 10.2217/fmb.11.82 21958142
3. The population dynamics and control of tuberculosis. Dye C, Williams BG, Science 2010 328 5980 856 861 10.1126/science.1185449 20466923
4. Life and death in the granuloma: immunopathology of tuberculosis. Saunders BM, Britton WJ, Immunol Cell Biol 2007 85 2 103 111 10.1038/sj.icb.7100027 17213830 (Pubitemid 46398725)
5. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view. Paige C, Bishai WR, Cell Microbiol 2010 12 3 301 309 10.1111/j.1462-5822.2009.01424.x 20039878
6. New insights into the function of granulomas in human tuberculosis. Ulrichs T, Kaufmann SH, J Pathol 2006 208 2 261 269 10.1002/path.1906 16362982 (Pubitemid 43126118)
7. The immunological life cycle of tuberculosis. Ernst JD, Nat Rev Immunol 2012 12 8 581 591 10.1038/nri3259 22790178
8. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Cooper AM, Khader SA, Immunol Rev 2008 226 191 204 10.1111/j.1600-065X.2008.00702.x 19161425
9. A review of murine models of latent tuberculosis infection. Shi C, Shi J, Xu Z, Scand J Infect Dis 2011 43 11-12 848 856 21892898
10. Experimental animal models of tuberculosis. JoAnne L, Flynn LT, Izzo A, Kaplan G, Handbook of Tuberculosis Weinheim: Wiley-VCH Verlag GmbH & Co, Stefan WJB, Kaufmann HE, 2008 389 426
11. What animal models teach humans about tuberculosis. Dharmadhikari AS, Nardell EA, Am J Respir Cell Mol Biol 2008 39 5 503 508 10.1165/rcmb.2008-0154TR 18556589
12. Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis. Manabe YC, Dannenberg AM Jr, Tyagi SK, Hatem CL, Yoder M, Woolwine SC, Zook BC, Pitt ML, Bishai WR, Infect Immun 2003 71 10 6004 6011 10.1128/IAI.71.10.6004-6011.2003 14500521 (Pubitemid 37205653)
13. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. Tsenova L, Ellison E, Harbacheuski R, Moreira AL, Kurepina N, Reed MB, Mathema B, Barry CE 3rd, Kaplan G, J Infect Dis 2005 192 1 98 106 10.1086/430614 15942899 (Pubitemid 40863862)
14. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. Manca C, Tsenova L, Barry CE 3rd, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G, J Immunol 1999 162 11 6740 6746 10352293 (Pubitemid 29309400)
15. Spontaneous latency in a rabbit model of pulmonary tuberculosis. Subbian S, Tsenova L, O'Brien P, Yang G, Kushner NL, Parsons S, Peixoto B, Fallows D, Kaplan G, Am J Pathol 2012 181 5 1711 1724 10.1016/j.ajpath.2012.07.019 22960076
16. Pulmonary Tuberculosis in the Rabbit. Kaplan G, Tsenova L, A color atlas of comparative pathology of pulmonary tuberculosis Singapore: CRC Press, Leong FJDV, Dick T, 2010 107 130
17. Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response. Subbian S, Tsenova L, Yang G, O'Brien P, Parsons S, Peixoto B, Taylor L, Fallows D, Kaplan G, Open Biol 2011 1 4 110016 10.1098/rsob.110016 22645653
18. Natural killer cell signaling pathways. Vivier E, Nunes JA, Vely F, Science 2004 306 5701 1517 1519 10.1126/science.1103478 15567854 (Pubitemid 39564941)
19. The bidirectional crosstalk between human dendritic cells and natural killer cells. Wehner R, Dietze K, Bachmann M, Schmitz M, J Innate Immun 2011 3 3 258 263 10.1159/000323923 21411969
20. Monocyte-derived inflammatory dendritic cells in the granuloma during mycobacterial infection. Schreiber HA, Sandor M, Adv Exp Med Biol 2012 946 277 293 21948374
21. Signaling in innate immunity and inflammation. Newton K, Dixit VM, Cold Spring Harb Perspect Biol 2012 4 3 006049 10.1101/cshperspect.a006049 22296764
22. Initiation and regulation of T-cell responses in tuberculosis. Urdahl KB, Shafiani S, Ernst JD, Mucosal Immunol 2011 4 3 288 293 10.1038/mi.2011.10 21451503
23. Autophagy: a core cellular process with emerging links to pulmonary disease. Haspel JA, Choi AM, Am J Respir Crit Care Med 2011 184 11 1237 1246 10.1164/rccm.201106-0966CI 21836133
24. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V, Cell 2004 119 6 753 766 10.1016/j.cell.2004.11.038 15607973 (Pubitemid 40017683)
25. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Ponpuak M, Davis AS, Roberts EA, Delgado MA, Dinkins C, Zhao Z, Virgin HW, Kyei GB, Johansen T, Vergne I, Deretic V, Immunity 2010 32 3 329 341 10.1016/j.immuni.2010.02.009 20206555
26. Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease. Gonzalez-Juarrero M, Kingry LC, Ordway DJ, Henao-Tamayo M, Harton M, Basaraba RJ, Hanneman WH, Orme IM, Slayden RA, Am J Respir Cell Mol Biol 2009 40 4 398 409 18787176
27. Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis. Chang JS, Huggett JF, Dheda K, Kim LU, Zumla A, Rook GA, J Immunol 2006 176 5 3010 3018 16493059
28. Toll-like receptor pathways in the immune responses to mycobacteria. Quesniaux V, Fremond C, Jacobs M, Parida S, Nicolle D, Yeremeev V, Bihl F, Erard F, Botha T, Drennan M, Soler MN, Le Bert M, Schnyder B, Ryffel B, Microbes Infect 2004 6 10 946 959 10.1016/j.micinf.2004.04.016 15310472 (Pubitemid 39061217)
29. Intracellular signalling cascades regulating innate immune responses to Mycobacteria: branching out from Toll-like receptors. Jo EK, Yang CS, Choi CH, Harding CV, Cell Microbiol 2007 9 5 1087 1098 10.1111/j.1462-5822.2007.00914.x 17359235 (Pubitemid 46547129)
30. Determinant role for Toll-like receptor signalling in acute mycobacterial infection in the respiratory tract. Tjarnlund A, Guirado E, Julian E, Cardona PJ, Fernandez C, Microbes Infect 2006 8 7 1790 1800 10.1016/j.micinf.2006.02.017 16815067 (Pubitemid 44128881)
31. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Drennan MB, Nicolle D, Quesniaux VJ, Jacobs M, Allie N, Mpagi J, Fremond C, Wagner H, Kirschning C, Ryffel B, Am J Pathol 2004 164 1 49 57 10.1016/S0002-9440(10)63095-7 14695318 (Pubitemid 38364589)
32. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR, J Exp Med 1993 178 6 2249 2254 10.1084/jem.178.6.2249 7504064 (Pubitemid 23344886)
33. Disseminated tuberculosis in interferon gamma gene-disrupted mice. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM, J Exp Med 1993 178 6 2243 2247 10.1084/jem.178.6.2243 8245795 (Pubitemid 23344885)
34. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Nathan C, Shiloh MU, Proc Natl Acad Sci U S A 2000 97 16 8841 8848 10.1073/pnas.97.16.8841 10922044 (Pubitemid 30626635)
35. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. Chan J, Xing Y, Magliozzo RS, Bloom BR, J Exp Med 1992 175 4 1111 1122 10.1084/jem.175.4.1111 1552282
36. Identification of nitric oxide synthase as a protective locus against tuberculosis. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF, Proc Natl Acad Sci U S A 1997 94 10 5243 5248 10.1073/pnas.94.10.5243 9144222 (Pubitemid 27214768)
37. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR, Infect Immun 1995 63 2 736 740 7529749
38. Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages. Sonawane A, Santos JC, Mishra BB, Jena P, Progida C, Sorensen OE, Gallo R, Appelberg R, Griffiths G, Cell Microbiol 2011 13 10 1601 1617 10.1111/j.1462-5822.2011.01644.x 21790937
39. Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis. Castaneda-Delgado J, Hernandez-Pando R, Serrano CJ, Aguilar-Leon D, Leon-Contreras J, Rivas-Santiago C, Mendez R, Gonzalez-Curiel I, Enciso-Moreno A, Rivas-Santiago B, Clin Exp Immunol 2010 161 3 542 550 10.1111/j.1365-2249.2010.04199.x 20636399
40. LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. van der Does AM, Beekhuizen H, Ravensbergen B, Vos T, Ottenhoff TH, van Dissel JT, Drijfhout JW, Hiemstra PS, Nibbering PH, J Immunol 2010 185 3 1442 1449 10.4049/jimmunol.1000376 20610648
41. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Rivas-Santiago B, Hernandez-Pando R, Carranza C, Juarez E, Contreras JL, Aguilar-Leon D, Torres M, Sada E, Infect Immun 2008 76 3 935 941 10.1128/IAI.01218-07 18160480 (Pubitemid 351428052)
42. Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Zughaier SM, Shafer WM, Stephens DS, Cell Microbiol 2005 7 9 1251 1262 10.1111/j.1462-5822.2005.00549.x 16098213 (Pubitemid 41179418)
43. Memory CD8+ T cells require CD28 costimulation. Borowski AB, Boesteanu AC, Mueller YM, Carafides C, Topham DJ, Altman JD, Jennings SR, Katsikis PD, J Immunol 2007 179 10 6494 6503 17982038
44. Co-stimulatory signals increase the reactivity of gammadelta T cells towards mycobacterial antigens. Gonzalez-Amaro R, Portales-Perez DP, Baranda L, Moncada B, Toro C, Lopez-Briones S, Espitia C, Mancilla R, Clin Exp Immunol 2000 120 3 468 475 10.1046/j.1365-2249.2000.01226.x 10844525 (Pubitemid 30365552)
45. CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation. Hunig T, Luhder F, Elflein K, Gogishvili T, Frohlich M, Guler R, Cutler A, Brombacher F, Med Microbiol Immunol 2010 199 3 239 246 10.1007/s00430-010-0156-z 20390297
46. Identification of Mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy. Li L, Qiao D, Fu X, Lao S, Zhang X, Wu C, PLoS One 2011 6 5 20165 10.1371/journal.pone.0020165 21625607
47. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. Herbst S, Schaible UE, Schneider BE, PLoS One 2011 6 5 19105 10.1371/journal.pone.0019105 21559306
48. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Worku S, Hoft DF, Infect Immun 2003 71 4 1763 1773 10.1128/IAI.71.4.1763-1773.2003 12654790 (Pubitemid 36368705)
49. CD8- and CD95/95 L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Turner J, D'Souza CD, Pearl JE, Marietta P, Noel M, Frank AA, Appelberg R, Orme IM, Cooper AM, Am J Respir Cell Mol Biol 2001 24 2 203 209 11159055 (Pubitemid 32152083)
50. Autophagy in the immune response to tuberculosis: clinical perspectives. Ni Cheallaigh C, Keane J, Lavelle EC, Hope JC, Harris J, Clin Exp Immunol 2011 164 3 291 300 10.1111/j.1365-2249.2011.04381.x 21438870
51. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Deretic V, Immunol Rev 2011 240 1 92 104 10.1111/j.1600-065X.2010. 00995.x 21349088
52. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Harris J, De Haro SA, Master SS, Keane J, Roberts EA, Delgado M, Deretic V, Immunity 2007 27 3 505 517 10.1016/j.immuni.2007.07. 022 17892853 (Pubitemid 47418681)
53. Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Castillo EF, Dekonenko A, Arko-Mensah J, Mandell MA, Dupont N, Jiang S, Delgado-Vargas M, Timmins GS, Bhattacharya D, Yang H, Hutt J, Lyons CR, Dobos KM, Deretic V, Proc Natl Acad Sci U S A 2012 109 46 3168 E3176 10.1073/pnas.1210500109 23093667
54. Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Barreiro LB, Tailleux L, Pai AA, Gicquel B, Marioni JC, Gilad Y, Proc Natl Acad Sci U S A 2012 109 4 1204 1209 10.1073/pnas.1115761109 22233810
55. Assessing the human immune system through blood transcriptomics. Chaussabel D, Pascual V, Banchereau J, BMC Biol 2010 8 84 10.1186/1741-7007-8-84 20619006
56. Molecular signatures for diagnosis of infection: application of microarray technology. Campbell CJ, Ghazal P, J Appl Microbiol 2004 96 1 18 23 10.1046/j.1365-2672.2003.02112.x 14678155 (Pubitemid 38177901)
57. Genome-wide transcription profiling of human sepsis: a systematic review. Tang BM, Huang SJ, McLean AS, Crit Care 2010 14 6 237 10.1186/cc9392 21190579
58. Immunological biomarkers of tuberculosis. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A, Nat Rev Immunol 2011 11 5 343 354 10.1038/nri2960 21475309
59. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. Subbian S, Tsenova L, O'Brien P, Yang G, Koo MS, Peixoto B, Fallows D, Dartois V, Muller G, Kaplan G, PLoS Pathog 2011 7 9 1002262 10.1371/journal.ppat.1002262 21949656
60. Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. Subbian S, Tsenova L, O'Brien P, Yang G, Koo MS, Peixoto B, Fallows D, Zeldis JB, Muller G, Kaplan G, Am J Pathol 2011 179 1 289 301 10.1016/j.ajpath.2011.03.039 21703411